Literature DB >> 31347075

Metabolomics and Biomarker Discovery.

Kathryn Sinclair1, Ed Dudley2.   

Abstract

Recently, metabolomics-the study of metabolite profiles within biological samples-has found a wide range of applications. This chapter describes the different techniques available for metabolomic analysis, the various samples that can be utilised for analysis and applications of both global and targeted metabolomic analysis to biomarker discovery in medicine.

Keywords:  Biomarkers; Metabolomics; Pancreatic cancer

Mesh：

Substances：

Year:  2019        PMID： 31347075     DOI： 10.1007/978-3-030-15950-4_37

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

2.  Amanida: An R package for Meta-analysis of metabolomics non-integral data.

Authors:  Llambrich Maria; Correig Eudald; Gumà Josep; Brezmes Jesús; Cumeras Raquel
Journal:  Bioinformatics       Date:  2021-08-18       Impact factor: 6.937

3.  A Metabolomic Analysis of Cirrhotic Ascites.

Authors:  Diren Beyoğlu; Cedric Simillion; Federico Storni; Andrea De Gottardi; Jeffrey R Idle
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

Review 4.  Metabolomics and Lipidomics: Expanding the Molecular Landscape of Exercise Biology.

Authors:  Mehdi R Belhaj; Nathan G Lawler; Nolan J Hoffman
Journal:  Metabolites       Date:  2021-03-07

5.  Predictive value of liver cirrhosis using metabolite biomarkers of bile acid in the blood: A protocol for systematic review and meta-analysis.

Authors:  Xu Han; Juan Wang; Hao Gu; Xing Liao; Miao Jiang
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

Review 6.  Perspectives from metabolomics in the early diagnosis and prognosis of gestational diabetes mellitus.

Authors:  Muqiu Zhang; Huixia Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-28       Impact factor: 6.055
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.